Ludovicus Staelens

1.1k citations

30 papers · 663 indexed · h-index 12

Radiology, Nuclear Medicine and Imaging top 5%
Molecular Biology
Psychiatry and Mental health top 10%
Immunology
Pediatrics, Perinatology and Child Health top 10%

Co-authors: Christophe Van de Wiele Guido Slegers Erik Remaut Pieter Rottiers Peter Casteels Jeroen Hostens Dirk Elewaut Els Beirnaert
Topics: Radiopharmaceutical Chemistry and Applications (6 papers)Medical Imaging Techniques and Applications (5 papers)Peptidase Inhibition and Analysis (5 papers)
Cited by: Radiology, Nuclear Medicine and Imaging Psychiatry and Mental health Cellular and Molecular Neuroscience
Journals: Neurology Epilepsia Toxicological Sciences
Partner nations: Belgium United States United Kingdom

In The Last Decade

Ludovicus Staelens

30 papers receiving 645 citations

Peers

Countries citing papers authored by Ludovicus Staelens

Since Specialization

Citations

This map shows the geographic impact of Ludovicus Staelens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ludovicus Staelens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ludovicus Staelens more than expected).

Fields of papers citing papers by Ludovicus Staelens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ludovicus Staelens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ludovicus Staelens. The network helps show where Ludovicus Staelens may publish in the future.

Co-authorship network of co-authors of Ludovicus Staelens

This figure shows the co-authorship network connecting the top 25 collaborators of Ludovicus Staelens. A scholar is included among the top collaborators of Ludovicus Staelens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ludovicus Staelens. Ludovicus Staelens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacokinetic interaction of brivaracetam on other antiepileptic drugs in adults with focal seizures: Pooled analysis of data from randomized clinical trials 2019 ·Epilepsy Research ·Brian D. Moseley,Christian Otoul,Ludovicus Staelens,Armel Stockis	9
2	Alpha synuclein dimers and oligomers are increased in overexpressing conditions in vitro and in vivo 2015 ·Molecular and Cellular Neuroscience ·Daniele Marmolino,Patrik Foerch,Franck Atienzar,Ludovicus Staelens,Anne Michel,D. Scheller	17
3	Cross-Species Differences in the Preclinical Pharmacokinetics of CT7758, an α4β1/α4β7 Integrin Antagonist 2015 ·Drug Metabolism and Disposition ·Hugues Chanteux,Ludovicus Staelens,(unknown),Brigitte Gerin,(unknown),Chandra Prakash,Jean‐Marie Nicolas	10
4	Brivaracetam, a selective high‐affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action 2015 ·Epilepsia ·Jean‐Marie Nicolas,Jonas Hannestad,Daniel Holden,Sophie Kervyn,Nabeel Nabulsi,D. Tytgat,Yiyun Huang,Hugues Chanteux,Ludovicus Staelens,Alain Matagne,François‐Xavier Mathy,Joël Mercier,Armel Stockis,Richard E. Carson,Henrik Klitgaard	123
5	Anti‐ictogenic and antiepileptogenic properties of brivaracetam in mature and immature rats 2015 ·Epilepsia ·Nina Dupuis,Alain Matagne,Ludovicus Staelens,Pascal Dournaud,Béatrice Desnous,Pierre Gressèns,Stéphane Auvin	23
6	N-Alkylprotoporphyrin Formation and Hepatic Porphyria in Dogs After Administration of a New Antiepileptic Drug Candidate: Mechanism and Species Specificity 2014 ·Toxicological Sciences ·Jean‐Marie Nicolas,Hugues Chanteux,(unknown),(unknown),Brigitte Gerin,Ludovicus Staelens,(unknown),Sophie Kervyn	6
7	123I-Interleukin-2 uptake in squamous cell carcinoma of the head and neck carcinoma 2007 ·European Journal of Nuclear Medicine and Molecular Imaging ·David S. Loose,Alberto Signore,Ludovicus Staelens,(unknown),Hubert Vermeersch,Rudi Dierckx,Elena Bonanno,Christophe Van de Wiele	18
8	Valine-based biphenylsulphonamide matrix metalloproteinase inhibitors as tumor imaging agents 2006 ·Applied Radiation and Isotopes ·Ruth Oltenfreiter,Ludovicus Staelens,Veerle Kersemans,Bart Cornelissen,Françis Frankenne,Jean‐Michel Foidart,Christophe Van de Wiele,Guido Slegers	12
9	Optimization by Experimental Design of Precursor Synthesis and Radiolabeling of 2-Iodo-L-Phenylalanine, a Novel Amino Acid for Tumor Imaging 2006 ·Cancer Biotherapy and Radiopharmaceuticals ·Veerle Kersemans,Ken Kersemans,Bart Cornelissen,Ludovicus Staelens,Bart De Spiegeleer,John Mertens,Guido Slegers	1
10	Formatted anti–tumor necrosis factor α VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen‐induced arthritis 2006 ·Arthritis & Rheumatism ·Ken Coppieters,Torsten Dreier,Karen Silence,Hans de Haard,Marc Lauwereys,Peter Casteels,Els Beirnaert,Heidi Jonckheere,Christophe Van de Wiele,Ludovicus Staelens,Jeroen Hostens,Hilde Revets,Erik Remaut,Dirk Elewaut,Pieter Rottiers	239
11	Tryptophane-Based Biphenylsulfonamide Matrix Metalloproteinase Inhibitors as Tumor Imaging Agents 2005 ·Cancer Biotherapy and Radiopharmaceuticals ·Ruth Oltenfreiter,Ludovicus Staelens,Soraya Labied,Veerle Kersemans,Françis Frankenne,Agnès Noël,Christophe Van de Wiele,Guido Slegers	14
12	Synthesis, quality control and in vivo evaluation of [¹²³I] rhTIMP‐2, a potential tumour‐imaging agent 2005 ·Journal of Labelled Compounds and Radiopharmaceuticals ·Ruth Oltenfreiter,Ingrid J.G. Burvenich,Ludovicus Staelens,Annabelle Lejeune,Françis Frankenne,Jean‐Michel Foidart,Guido Slegers	3
13	In vitro and in vivo evaluation of [123I]-VEGF165 as a potential tumor marker 2005 ·Nuclear Medicine and Biology ·Bart Cornelissen,Ruth Oltenfreiter,Veerle Kersemans,Ludovicus Staelens,Françis Frankenne,Jean-Michel Foidart,Guido Slegers	25
14	In vivo evaluation of [123I]-4-iodo-N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide: a potential sigma receptor ligand for SPECT studies 2005 ·Nuclear Medicine and Biology ·Ludovicus Staelens,Ruth Oltenfreiter,Filip Dumont,Rikki N. Waterhouse,(unknown),Peter Blanckaert,Rudi Dierckx,Guido Slegers	7
15	Comparison between 1 T MRI and non-MRI based volumetry in inoculated tumours in mice 2005 ·British Journal of Radiology ·Bart Cornelissen,Veerle Kersemans,(unknown),Ludovicus Staelens,Ruth Oltenfreiter,(unknown),Eric Achten,Guido Slegers	9
16	Synthesis, radiosynthesis, in vitro and preliminary in vivo evaluation of biphenyl carboxylic and hydroxamic matrix metalloproteinase (MMP) inhibitors as potential tumor imaging agents 2005 ·Applied Radiation and Isotopes ·Ruth Oltenfreiter,Ludovicus Staelens,Ulrik Hillaert,(unknown),Agnès Noël,Françis Frankenne,Guido Slegers	8
17	New radioiodinated carboxylic and hydroxamic matrix metalloproteinase inhibitor tracers as potential tumor imaging agents 2004 ·Nuclear Medicine and Biology ·Ruth Oltenfreiter,Ludovicus Staelens,Annabelle Lejeune,Filip Dumont,Françis Frankenne,Jean‐Michel Foidart,Guido Slegers	23
18	Synthesis, radiosynthesis and in vivo evaluation in mice of [123I]-(4-fluorophenyl) {1-[2-(4-iodophenyl)ethyl]piperidin-4-yl}methanone for visualization of the 5-HT2A receptor with SPECT 2004 ·Applied Radiation and Isotopes ·Peter Blanckaert,Ingrid J.G. Burvenich,Ludovicus Staelens,R. A. Dierckx,Guido Slegers	5
19	Synthesis and radiolabelling of [¹²³I]‐4‐iodo‐N‐(4‐(4‐(2‐methoxyphenyl)‐piperazin‐1‐yl)butyl)‐benzamide, a potential dopamine D₃ antagonist for SPECT studies 2003 ·Journal of Labelled Compounds and Radiopharmaceuticals ·Ludovicus Staelens,F. Dumont,Filip De Vos,Ruth Oltenfreiter,(unknown),R. A. Dierckx,Guido Slegers	2
20	Title: Synthesis, biodistribution and blocking studies in mice of a new 123I-labeled dopamine D3 antagonist Dierckx RA, Slegers G 2001 ·Ghent University Academic Bibliography (Ghent University) ·Ludovicus Staelens,Filip Dumont,(unknown),Ruth Oltenfreiter,(unknown),Ingeborg Goethals,Rudi Dierckx,Guido Slegers	1

About Ludovicus Staelens

Ludovicus Staelens is a scholar working on Immunology and Allergy, Cancer Research and Oncology, having authored 30 papers that have together received 663 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (6 papers), Medical Imaging Techniques and Applications (5 papers) and Peptidase Inhibition and Analysis (5 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (236 citations), Psychiatry and Mental health (150 citations) and Cellular and Molecular Neuroscience (139 citations). Ludovicus Staelens has collaborated with scholars based in Belgium, United States and United Kingdom. Frequent co-authors include Christophe Van de Wiele, Guido Slegers, Erik Remaut, Pieter Rottiers, Peter Casteels, Jeroen Hostens, Dirk Elewaut, Els Beirnaert, Ken Coppieters and Marc Lauwereys. Their work appears in journals such as Neurology, Epilepsia and Toxicological Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact